AlzeCure Pharma
Research AlzeCure Pharma (ALZCUR) on Bullrun: market cap SEK 447.02M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALZCUR
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 447.02M
- Financial periodQ4 2025
- Net income-SEK 17.74M
- Free cash flow-SEK 8.58M
Valuation Snapshot
latest market cap is SEK 447.02M.
About AlzeCure Pharma
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms.
Frequently asked questions
What is AlzeCure Pharma's market cap?
AlzeCure Pharma's market capitalization is SEK 447.02M.
What does AlzeCure Pharma do?
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.